Search research articles
Contact Us
Filters
Showing results (581-590 of 616) with videos related to
Page
of 62
Sort By:
Clinical Pharmacology and Therapeutics
|
July 10, 2014
Accelerated access to innovative medicines for patients in need
L G Baird, R Banken, H-G Eichler, et al.
Cell Reports
|
June 20, 2020
High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vδ2<sup>+</sup> T Cell Subset with a MAIT Cell-like Transcriptional Profile
Kathleen M Wragg, Hyon-Xhi Tan, Anne B Kristensen, et al.
Biochemia Medica
|
June 22, 2019
European survey on preanalytical sample handling - Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
Janne Cadamuro, Giuseppe Lippi, Alexander von Meyer, et al.
Molecular Cancer
|
July 27, 2005
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
Marci E Schaner, Ben Davidson, Martina Skrede, et al.
Biochemia Medica
|
June 22, 2019
European survey on preanalytical sample handling - Part 1: How do European laboratories monitor the preanalytical phase? On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
Janne Cadamuro, Giuseppe Lippi, Alexander von Meyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2012
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
K Lindemann, R D Christensen, I Vergote, et al.
Lancet (London, England)
|
June 27, 2003
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
M K B Parmar, J A Ledermann, N Colombo, et al.
Heliyon
|
July 23, 2024
Deep learning for automated scoring of immunohistochemically stained tumour tissue sections - Validation across tumour types based on patient outcomes
Wanja Kildal, Karolina Cyll, Joakim Kalsnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma
L S Hofstra, G B Kristensen, P H Willemse, et al.
The British Journal of Dermatology
|
May 7, 2009
Clinical severity and prognosis of hand eczema
M Hald, T Agner, J Blands, et al.
Page
of 62
Search research articles
Search
Showing results (581-590 of 616) with videos related to
Sort By:
Page
of 62
Clinical Pharmacology and Therapeutics
|
July 10, 2014
Accelerated access to innovative medicines for patients in need
L G Baird, R Banken, H-G Eichler, et al.
Cell Reports
|
June 20, 2020
High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vδ2<sup>+</sup> T Cell Subset with a MAIT Cell-like Transcriptional Profile
Kathleen M Wragg, Hyon-Xhi Tan, Anne B Kristensen, et al.
Biochemia Medica
|
June 22, 2019
European survey on preanalytical sample handling - Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
Janne Cadamuro, Giuseppe Lippi, Alexander von Meyer, et al.
Molecular Cancer
|
July 27, 2005
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
Marci E Schaner, Ben Davidson, Martina Skrede, et al.
Biochemia Medica
|
June 22, 2019
European survey on preanalytical sample handling - Part 1: How do European laboratories monitor the preanalytical phase? On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
Janne Cadamuro, Giuseppe Lippi, Alexander von Meyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2012
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
K Lindemann, R D Christensen, I Vergote, et al.
Lancet (London, England)
|
June 27, 2003
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
M K B Parmar, J A Ledermann, N Colombo, et al.
Heliyon
|
July 23, 2024
Deep learning for automated scoring of immunohistochemically stained tumour tissue sections - Validation across tumour types based on patient outcomes
Wanja Kildal, Karolina Cyll, Joakim Kalsnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma
L S Hofstra, G B Kristensen, P H Willemse, et al.
The British Journal of Dermatology
|
May 7, 2009
Clinical severity and prognosis of hand eczema
M Hald, T Agner, J Blands, et al.
Page
of 62